Current Research

33 Active Projects at 28 Institutions in 21 Diseases in 8 Countries

 

Researchers work on current repurposing research projectsWe support investigator-initiated repurposing research projects in any unsolved disease including cardio, neuro, oncology, ophthalmic, vascular and rare diseases in pediatrics and adults. We support projects from accredited academic and nonprofit research institutions and large group medical practices located anywhere in the world. Our Impact Awards support early-stage companies bringing a repurposed treatment to market.

We take an impact philanthropy approach that prioritizes patient when selecting repurposing research projects. We support both philanthropic projects, which have little or no commercial value but have critical value to patients, as well as commercial projects, which industry may bring to regulatory approval and then to market. Our proof-of-concept funding of repurposing projects allows researchers and clinicians to leverage positive data into follow-on funding.

Our current projects were selected through a two-stage submission process. Applicants submit a brief proposal submissions usually followed by full grant applications. Project proposals are reviewed by an external, volunteer Grant Review Committee which represents academia, industry, clinicians and the patient voice. The committee helps staff and the Science Advisory Board select the strongest projects. Our customized approach allows donors to be as involved in the entire process as desired.

The diversity of our current projects reflects our disease-agnostic, patient-first approach:

  • more than 75% adult, less than 25% pediatric
  • more than 85% clinical, less than 15% pre-clinical
  • more than 75% drug, less than 25% device or other
  • more than 75% US-based, less than 25% outside of the US

 

Current Repurposing Research Projects

DISEASE AREAINSTITUTIONLEAD RESEARCHERPROJECT NAMETYPEOTHERSTATUS
DiabetesMassachusetts General HospitalDr. FaustmanRepurposing a Vaccine for Type I DiabetesVaccineAdultIn Process
Diabetic OphthalmologyNorthwestern UniversityDr. BastiTreating Cataracts in Diabetic Patients Using a Surgical DeviceDeviceAdultIn Process
Infectious DiseaseObafemi Awolowo University & Teaching Hospitals ComplexProf. AdewoleTreating Tuberculosis with the Lipid Lowering Drug Atorvastatin in NigeriaDrugAdultStarted 2020
Infectious DiseaseGeorge Washington University, Universidad El BosqueDr. ChangRepurposing a Flu Treatment for Severe Dengue Patients in ColombiaDrugPediatricStarted 2020
Infectious DiseaseUniversity of ChicagoDr. MeltzerCan Vitamin D Reduce the Burden of COVID-19 in Chicago?NutraceuticalAdultStarted 2020
Infectious DiseaseNorthwestern UniversityDr. RadoRepurposing an Antidepressant to Prevent Hospitalization in COVID-19DrugAdultStarted 2020
Infectious Disease/Inner EarUniversity of UtahDr. RowerRepurposing the Antiviral Drug Valganciclovir to Treat Cytomegalovirus-Induced Hearing Loss DrugPediatricStarted 2021
Inner EarCurtin UniversityDr. BrownTesting a generic diuretic to improve drug delivery to the inner ear in Meniere’s diseaseDrugPre-clinicalStarted 2020
Inner EarHouse Ear InstituteDr. DereberyReducing vertigo and hearing loss in Meniere’s disease by repurposing a common allergy drugDrugAdultStarted 2020
Inner EarStanford MedicineDr. GrimesModulating inner ear fluid regulation to treat Meniere’s diseaseDrugPre-ClinicalStarted 2020
Inner EarThe Feinstein Institutes for Medical ResearchDr. PathakInvestigating the effects of repurposed diuretic, steroid and immunosuppressive drugs in Meniere’s diseaseDrugPre-ClinicalStarted 2020
Inner EarMedical University of South CarolinaDr. RizkAssessing the efficacy of an antidepressant for improving vertigo attacks in Meniere’s diseaseDrugAdultStarted 2020
Inner EarHospital of the Ludwig-Maximilians University, MunichDr. StruppCombining a vertigo drug with a Parkinson’s disease drug to treat the inner ear disorder, Meniere’s diseaseDrugAdultIn Process
Inner EarDent Neurologic Institute Dr. ZhangCombining an anti-epileptic drug  with an anti-anxiety drug to treat the inner ear disorder Meniere’s diseaseDrugAdultIn Process
NeuroThe Pennsylvania State University and the Milton S. Hershey Medical CenterDr. ElfarRepurposing a Multiple Sclerosis Drug in Severe Limb Trauma*Drug into DiagnosticAdultIn Process
NeuroJohns Hopkins MedicineDr. Kumar, WangRepurposing Over the Counter Cough Medicine as a Rapid Acting AntidepressantDrugAdultIn Process
NeuroShirley Ryan AbilityLabDr. LieberRepurposing a Blood Cancer Treatment to Treat Muscle Contractures in Cerebral Palsy Patients*DrugPediatricStarted 2020
Neuro/RareGeorgetown University Dr. AndersonUsing a Cancer Drug in Huntington's Disease DrugAdultIn Process
Neuro/RareMcGovern Medical School at The University of Texas Health Science Center at HoustonDr. Furr-StimmingTreating Irritability in Huntington’s Disease with a Repurposed Neurological DrugDrugAdultIn Process
OncologyThe Hospital for Sick ChildrenDr. SuwwanLow-Level Laser Therapy to Address Treatment Side Effects in Pediatric Cancer PatientsDevicePediatricIn Process
Oncology/RareUniversity of CambridgeProf. AllenTesting Two Generic Drugs to Improve Outcomes in Osteosarcoma, a Rare Bone CancerDrugPre-ClinicalStarted 2021
Oncology/RareUniversity of California, IrvineDr. FleischmanTreating a Group of Rare Blood Cancers, Myeloproliferative Neoplasms, with a Nutraceutical*NutraceuticalAdultStarted 2020
Oncology/RareUniversity of MichiganDr. PettitUsing a Skin Cancer Drug to Improve Current Treatment in a Rare Blood Cancer, MyelofibrosisDrugAdultIn Process
Oncology/RareUniversity of MichiganDr. PhillipsImproving Patient Response in Mantle Cell Lymphoma with VenetoclaxDrug  AdultStarted 2020
Oncology/RareChildren’s Hospital of PhiladelphiaDr. SeifPreventing Relapse After Bone Marrow Transplant in Pediatric Acute Lymphoblastic Leukemia (ALL) with a Personalized TreatmentDrug PediatricStarted 2020
Oncology/RareUniversity of MichiganDr. SwiecickiRepurposing Old Drugs as New Therapies for Metastatic Thyroid Cancer*Drug  AdultIn Process
Oncology/RareMassachusetts General Hospital/Harvard Medical School, VUmc Cancer Center AmsterdamDrs. Tannous, Arrillaga-Romany, KouwenhovenA Novel Combination of Generic Chemotherapy Drugs to Treat Brain CancerDrugAdultIn Process
Ophthalmic/RareUniversity of California, DavisDr. ParkRepurposing Bone Marrow Stem Cell Therapy for Vision Loss Caused by Retinitis Pigmentosa OtherAdultStarted 2020
Ophthalmic/RareUniversity of MichiganDr. ZacksTesting a Generic Malarial Drug in a Rare Ophthalmic Condition, Retinitis Pigmentosa DrugAdultIn Process
OtherKEMRI-Wellcome Trust Research ProgrammeDr. HamalubaTesting the Safety of a Metal Poisoning Drug to Treat Snakebite in KenyaDrugAdultStarted 2020
Rare The Hospital for Sick Children, National Institutes of HealthDrs. Dowling, BönnemannTAM4MTM: Tamoxifen Therapy for Myotubular MyopathyDrug PediatricIn Process 
RareVietnam National Children’s Hospital/Big Leap ResearchDr. NguyenImproving Outcomes for the Rare Liver Disease Biliary Atresia with a Cancer Drug in VietnamDrugPediatricStarted 2021
RareSt. Jude Children’s Research HospitalDr. NicholsRepurposing a Blood Cancer Drug to Treat an Immune Disorder (HLH) in Children*DrugPediatricIn Process

*CureAccelerator Live! winner